Regulus Therap (RGLS) Reports Q4 Loss of 22c
Regulus Therap (NASDAQ: RGLS) reported Q4 EPS of ($0.22). May ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)